The Georgia Clinical and Translational Science Alliance (GaCTSA) is a compelling partnership of Emory University, Morehouse School of Medicine, the Georgia Institute of Technology and the University of Georgia, a new academic member adding resources and assets to our CTSA. Also key to GaCTSA are our healthcare partners: Emory Healthcare, Morehouse Healthcare, Children?s Healthcare of Atlanta, the Atlanta VA Medical Center, the Grady Health System, and the Atlanta Community Physicians Network and our translational science partners including the Yerkes National Primate Research Center (located at Emory), the Georgia Research Alliance, Georgia Bio and links to the Prevention Research Centers of the US Centers for Disease Control and Prevention (CDC). Built over the past decade of collaboration, the partners of GaCTSA have forged strong research networks and GaCTSA has become a ?24 hour? home and catalyst for innovative, high quality clinical and translational research with local, national and global impact. The addition of UGA allows the GaCTSA to better engage the large, rural and underserved populations of our state and adds new resources, including: outstanding translational research in glycobiology, infectious diseases, One Health, a new clinical and translational research unit, outstanding programs in Education, a School of Pharmacy; a robust extension service that reaches beyond its original agricultural mission to focus on family health; and the Archway Partnership whose mission is to connect Georgia communities with higher education resources to address critical, locally identified community needs. In addition to facilitating innovative science, GaCTSA will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research and accelerate the process of translating biomedical discoveries into clinical applications. Key to the next funding cycle, GaCTSA will emphasize innovative training and workforce development, access to and integration of special and underserved populations, enhanced biomedical informatics support and capabilities, new methods and processes to improve quality and efficiency, enhanced collaboration and engagement and team-based, quality focused predictive science.
The specific aims of GaCTSA reflect the vision and goals of NCATS Advisory Council Working Group and the recommendations of the 2013 IOM review of the CTSA program. The GaCTSA?s specific aims will serve as guiding principles to drive the vision and approach.

Public Health Relevance

Created in response to the NIH CTSA program, the Georgia Clinical & Translational Science Alliance (GaCTSA) serves as a catalyst and incubator for clinical and translational research across Georgia and with regional and national impact. In addition to facilitating innovative science, we will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research, and accelerate the process of translating biomedical discoveries into clinical applications.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR002378-02
Application #
9569744
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Davis Nagel, Joan
Project Start
2017-09-22
Project End
2022-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Summers, Nathan A; Kempker, Russell; Palacio, Federico (2018) Mycobacterium abscessus subspecies massiliense infection after skin graft and cholecystectomy in a burn patient. Int J Infect Dis 76:29-31
Grunwell, Jocelyn R; Stephenson, Susan T; Tirouvanziam, Rabindra et al. (2018) Children with Neutrophil-Predominant Severe Asthma Have Proinflammatory Neutrophils With Enhanced Survival and Impaired Clearance. J Allergy Clin Immunol Pract :
Brust, James C M; Shah, N Sarita; Mlisana, Koleka et al. (2018) Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa. Clin Infect Dis 66:1246-1253
Wang, Jiaxing; Li, Ying; King, Rebecca et al. (2018) Optic nerve regeneration in the mouse is a complex trait modulated by genetic background. Mol Vis 24:174-186
IeDEA and COHERE Cohort Collaborations (2018) Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis 66:893-903
Umpierrez, Guillermo E; Cardona, Saumeth; Chachkhiani, David et al. (2018) A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial. J Am Med Dir Assoc 19:399-404.e3
Guercio, Cailey; Mehta, Akanksha (2018) Predictors of Patient and Partner Satisfaction Following Radical Prostatectomy. Sex Med Rev 6:295-301
Umpierrez, Guillermo E; Klonoff, David C (2018) Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 41:1579-1589
Reaves, Barbara J; Wallis, Connor; McCoy, Ciaran J et al. (2018) Recognition and killing of Brugia malayi microfilariae by human immune cells is dependent on the parasite sample and is not altered by ivermectin treatment. Int J Parasitol Drugs Drug Resist 8:587-595
Wang, Tiffany; Kraft, Colleen S; Woodworth, Michael H et al. (2018) Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections. Open Forum Infect Dis 5:ofy016

Showing the most recent 10 out of 87 publications